VR

Venkatasubrahmanayan Ravi Chandran

Director Director DIN 00019172
DIN 00019172 First appointment Feb 2004 Primary industry Research & Development
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2004
Shareholding value •••• Premium profile

About Venkatasubrahmanayan Ravi Chandran

Data last updated:

Venkatasubrahmanayan Ravi Chandran was a Director at Stinson Molecular Ventures Private Limited (2006–2010) and Director at Mccormick Pharma Holdings Private Limited (2004–2010). The companies operate in Research & Development.

DIN 00019172
Primary Designation Director
Industry Research & Development
First Appointment 19 Feb 2004

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Mar 20062006Strike Off
Director19 Feb 20042004Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Stinson Molecular Ventures Private Limited
Mccormick Pharma Holdings Private Limited
Premium access

Shareholding and investment profile for Venkatasubrahmanayan Ravi Chandran

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkatasubrahmanayan Ravi Chandran

Venkatasubrahmanayan Ravi Chandran was first appointed on 19 Feb 2004 as Director at Mccormick Pharma Holdings Private Limited. The most recent appointment on record is 23 Mar 2006 at Stinson Molecular Ventures Private Limited.

Venkatasubrahmanayan Ravi Chandran held 2 earlier board appointments: Stinson Molecular Ventures Private Limited (Director, 23 Mar 2006 to 01 Oct 2010); Mccormick Pharma Holdings Private Limited (Director, 19 Feb 2004 to 01 Oct 2010).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available